Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease

LK Mydock-McGrane, TJ Hannan… - Expert opinion on drug …, 2017 - Taylor & Francis
ABSTRACT Introduction: The bacterial adhesin FimH is a virulence factor and an attractive
therapeutic target for urinary tract infection (UTI) and Crohn's Disease (CD). Located on type …
被引用次数：98 相关文章

Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.

LK Mydock-McGrane, TJ Hannan… - Expert Opinion on Drug …, 2017 - europepmc.org
The bacterial adhesin FimH is a virulence factor and an attractive therapeutic target for
urinary tract infection (UTI) and Crohn's Disease (CD). Located on type 1 pili of …

Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease

LK Mydock-McGrane, TJ Hannan… - Expert opinion on …, 2017 - pubmed.ncbi.nlm.nih.gov
The bacterial adhesin FimH is a virulence factor and an attractive therapeutic target for
urinary tract infection (UTI) and Crohn's Disease (CD). Located on type 1 pili of …

Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease

LK Mydock-McGrane, TJ Hannan… - Expert Opinion on Drug …, 2017 - profiles.wustl.edu
Abstract Introduction: The bacterial adhesin FimH is a virulence factor and an attractive
therapeutic target for urinary tract infection (UTI) and Crohn's Disease (CD). Located on type …

Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease

LK Mydock-Mcgrane, TJ Hannan… - Expert Opinion on Drug …, 2017 - hero.epa.gov
Abstract Introduction: The bacterial adhesin FimH is a virulence factor and an attractive
therapeutic target for urinary tract infection (UTI) and Crohn's Disease (CD). Located on type …
[HTML] nih.gov

[HTML][HTML] Rational Design Strategies for FimH Antagonists: New Drugs on the Horizon for Urinary Tract Infection and Crohn's Disease

LK Mydock-McGrane, TJ Hannan… - Expert opinion on drug …, 2017 - ncbi.nlm.nih.gov
Abstract Introduction—The bacterial adhesin FimH is a virulence factor and an attractive
therapeutic target for urinary tract infection (UTI) and Crohn's Disease (CD). Located on type …

Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.

LK Mydock-McGrane, TJ Hannan… - Expert Opinion on Drug …, 2017 - europepmc.org
Abstract Introduction—The bacterial adhesin FimH is a virulence factor and an attractive
therapeutic target for urinary tract infection (UTI) and Crohn's Disease (CD). Located on type …